Literature DB >> 17278233

Evaluation of prognostic markers in severe drug-induced liver disease.

Bo Li1, Zhi Wang, Jian-Jiang Fang, Ci-Yi Xu, Wei-Xing Chen.   

Abstract

AIM: To analyze the outcome of patients with severe drug-induced liver disease (DILD) associated with jaundice classified as hepatocellular, cholestatic or mixed liver injury and to evaluate the validity of Hyos rule and the most important predictors for outcome.
METHODS: The Adverse Drug Reaction Advisory Committee was set up in 1997 in our hospital to identify all suspicions of DILD following a structured prospective report form. Liver damage was divided into hepatocellular, cholestatic, and mixed types according to laboratory and histologic criteria when available. Further evaluation of causality assessment was performed.
RESULTS: From January 1997 to December 2004, 265 patients were diagnosed with DILD, and 140 (52.8%) of them were female. hepatocellular damage was the most common (72.1%), the incidence of death was 9.9% in patients with hepatocellular damage and 9.5% in patients with cholestatic/mixed damage (P < 0.05). There was no difference in age of dead and recovered patients. The proportion of females and males was similar in recovered and dead patients, no difference was observed in duration of treatment between the two groups. The serum total bilirubin (P < 0.001), direct bilirubin (P < 0.001) and aspartate transaminase (AST) (P = 0.013) values were higher in dead patients than in recovered patients. Chinese herbal medicine was the most frequently prescribed, accounting for 24.2% of the whole series. However, antitubercular drugs (3.4%) were found to be the primary etiological factor for fetal DILD. Factors associated with the development of fulminant hepatic failure were hepatic encephalopathy (OR = 43.66, 95% CI = 8.47-224.95, P < 0.0001), ascite (OR = 28.48, 95% CI = 9.26-87.58, P < 0.0001), jaundice (OR = 11.43, 95% CI = 1.52-85.96, P = 0.003), alcohol abuse (OR = 3.83, 95% CI = 1.26-11.67, P = 0.035) and direct bilirubin (OR = 1.93, 95% CI = 1.25-2.58, P = 0.012).
CONCLUSION: Death occurs in 9.8% of patients with DILD. Chinese herbal medicine stands out as the most common drug for DILD. While antitubercular drugs are found to be the primary etiological factor for fetal DILD, hepatic encephalopathy, ascites, jaundice, alcohol abuse and direct bilirubin levels are associated with the death of DILD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17278233      PMCID: PMC4065989          DOI: 10.3748/wjg.v13.i4.628

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

2.  Clinical characteristics and prognostic indicators of drug-induced fulminant hepatic failure.

Authors:  Shigeru Ohmori; Katsuya Shiraki; Hidekazu Inoue; Hiroshi Okano; Takenari Yamanaka; Masatoshi Deguchi; Takahisa Sakai; Koujiro Takase; Takeshi Nakano; Yukihiko Tameda
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

Review 3.  Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Authors:  C Bénichou
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

Review 4.  Drug-induced liver disease.

Authors:  H J Zimmerman
Journal:  Clin Liver Dis       Date:  2000-02       Impact factor: 6.126

Review 5.  Drug-induced hepatotoxicity.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1995-10-26       Impact factor: 91.245

6.  Isoniazid-associated hepatitis in 114 patients.

Authors:  M Black; J R Mitchell; H J Zimmerman; K G Ishak; G R Epler
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

7.  Incidence of drug-induced hepatic injuries: a French population-based study.

Authors:  Catherine Sgro; François Clinard; Kader Ouazir; Henry Chanay; Christian Allard; Christian Guilleminet; Claude Lenoir; Alain Lemoine; Patrick Hillon
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

8.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

Authors:  G Danan; C Benichou
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437

9.  Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987.

Authors:  H Friis; P B Andreasen
Journal:  J Intern Med       Date:  1992-08       Impact factor: 8.989

  9 in total
  18 in total

1.  Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population.

Authors:  Jaeseong Jo; Ji Eun Yun; Heeyeon Lee; Heejin Kimm; Sun Ha Jee
Journal:  Endocrine       Date:  2010-11-30       Impact factor: 3.633

2.  Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.

Authors:  Adrian Reuben; David G Koch; William M Lee
Journal:  Hepatology       Date:  2010-10-14       Impact factor: 17.425

3.  Trypanosoma brucei brucei Induced Hypoglycaemia Depletes Hepatic Glycogen and Altered Hepatic Hexokinase and Glucokinase Activities in Infected Mice.

Authors:  Rotimi Johnson Ojo; Grace Manmak Paul; Dorcas Dedan Magellan; Dogwo Nahum Dangara; Gideon Gyebi
Journal:  Acta Parasitol       Date:  2022-04-27       Impact factor: 1.534

4.  Rifampicin-isoniazid induced fatal fulminant hepatitis during treatment of latent tuberculosis: A case report and literature review.

Authors:  Fahmi Yousef Khan; Fatima Rasoul
Journal:  Indian J Crit Care Med       Date:  2010-04

Review 5.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

6.  Association of serum bilirubin with ischemic stroke outcomes.

Authors:  Sandra Pineda; Oh Young Bang; Jeffrey L Saver; Sidney Starkman; Susan W Yun; David S Liebeskind; Doojin Kim; Latisha K Ali; Samir H Shah; Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 May-Jun       Impact factor: 2.136

7.  Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.

Authors:  Nanjegowda Sunil Kumar; Bhavith Remalayam; Varghese Thomas; Thazhath M Ramachandran; Kandiyil Sunil Kumar
Journal:  J Clin Exp Hepatol       Date:  2020-08-20

8.  Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus.

Authors:  P Daisy; K Saipriya
Journal:  Int J Nanomedicine       Date:  2012-03-07

9.  Cigarette smoking and serum bilirubin subtypes in healthy Korean men: the Korea Medical Institute study.

Authors:  Jaeseong Jo; Heejin Kimm; Ji Eun Yun; Kyu Jang Lee; Sun Ha Jee
Journal:  J Prev Med Public Health       Date:  2012-03-31

10.  Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury.

Authors:  Jia-Bo Wang; Yun Zhu; Zhao-Fang Bai; Fu-Sheng Wang; Xiu-Hui Li; Xiao-He Xiao
Journal:  Chin J Integr Med       Date:  2018-03-15       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.